Cardiac involvement in anti-GABA-B receptor encephalitis: a case report Authors: Rosa Ferrer Tarrés, Alexis García Sarreón, Francisco Pozo Ariza, Jorge Gutiérrez Naranjo, Ariadna Gifreu-Fraixinó, Almudena Boix-Lago, Gary Álvarez-Bravo Published: 2025 ABSTRACT AbstractBackgroundAnti-gamma-aminobutyric acid B receptor (GABA-B R) encephalitis is an uncommon autoimmune disorder typically presenting with seizures, memory impairment and a frequent paraneoplastic association with small cell lung carcinoma. Although GABA-B Rs are expressed in cardiac tissue, extracerebral manifestations have rarely been described.Case presentationA 65-year-old man presented with status epilepticus. Cerebrospinal fluid (CSF) analysis revealed mild lymphocytic pleocytosis and type 3 oligoclonal bands. Anti-GABA-B R antibodies were detected in serum and CSF, confirming the diagnosis of autoimmune encephalitis. The patient improved after high-dose intravenous corticosteroids but died unexpectedly during recovery. Autopsy revealed perivascular CD3-positive lymphocytic infiltration in the brain and meninges, consistent with autoimmune encephalitis, and metastatic neuroendocrine carcinoma compatible with a pulmonary primary. Notably, CD3-positive lymphocytic infiltration was also found within myocardial fibres, consistent with lymphocytic myocarditis.ConclusionsThis case broadens the recognised spectrum of anti-GABA-B R encephalitis and raises the possibility of cardiac involvement in this disorder. The presence of GABA-B Rs in cardiomyocytes offers a potential link between receptor autoimmunity and myocardial inflammation. Although causality cannot be established, these findings suggest that cardiac monitoring may be advisable in patients with anti-GABA-B R encephalitis, particularly in paraneoplastic contexts.Keywords: NEUROIMMUNOLOGY, IMMUNOLOGY Introduction The metabotropic gamma-aminobutyric acid B receptor (GABA-B R) plays a crucial role in inhibitory neurotransmission. Disruption by GABA-B R antibodies has been linked to seizures and cognitive impairment.1 In 2010, Lancaster et al described patients with limbic encephalitis in whom IgG1 antibodies targeted the GABA-B R B1 subunit, establishing this disorder as an immune-mediated or paraneoplastic encephalitis.2 Since then, clinical series have confirmed a core phenotype consisting of early seizures, memory dysfunction and variable psychiatric symptoms.3 Roughly half of reported cases are associated with small cell lung carcinoma or other neuroendocrine tumours, underlining its paraneoplastic character. Despite the increasing recognition of anti-GABA-B R encephalitis, extracerebral manifestations remain poorly defined. Experimental studies have shown that GABA-B Rs are expressed in cardiac tissue, but their relevance in human disease has rarely been explored. We describe a patient with confirmed anti-GABA-B R encephalitis who improved with immunotherapy but died unexpectedly. Autopsy revealed concomitant autoimmune myocarditis, suggesting that cardiac involvement may represent a rare but clinically important extension of the disease spectrum. Case history The patient was a 65-year-old man with a medical history of hypertension, dyslipidaemia, type 2 diabetes mellitus, lumbar spinal stenosis and long-term tobacco use. He had been previously independent and reported no family history of autoimmune or neurological disease. He presented to the emergency department with the abrupt onset of recurrent generalised tonic–clonic seizures. Witnesses described an initial focal seizure with impaired awareness that rapidly evolved into bilateral tonic–clonic activity, followed by repeated convulsions without complete recovery of consciousness. Orotracheal intubation was required for airway protection. On admission, initial laboratory investigations demonstrated normal electrolytes, renal and hepatic function, lipid profile and inflammatory markers. Non-contrast CT of the head revealed no acute lesion. He was admitted to the intensive care unit (ICU) and initiated on intravenous levetiracetam. Cerebrospinal fluid (CSF) analysis demonstrated a mild lymphocytic pleocytosis (18 cells/µL, 92% lymphocytes), with protein 68 mg/dL and glucose 63 mg/dL (serum glucose 108 mg/dL). Empirical intravenous acyclovir was administered for suspected viral encephalitis. Oligoclonal bands revealed a type 3 pattern, with identical bands in serum and CSF plus additional bands restricted to the CSF, consistent with intrathecal synthesis. A multiplex PCR panel for herpes simplex virus, varicella zoster virus, enteroviruses, cytomegalovirus, Epstein-Barr virus and common bacterial pathogens was negative. MRI of the brain with contrast was unremarkable, with no medial temporal lobe hyperintensity. Thoracoabdominal CT showed no evidence of masses or lymphadenopathy. Sedated EEG demonstrated diffuse slowing, consistent with encephalopathy, without epileptiform discharges. Serological screening for paraneoplastic antibodies against intracellular antigens (Hu, Yo, Ri, Tr, CV2/CRMP5, amphiphysin, Ma2/Ma1, SOX1, ZIC4, GAD, GFAP, AK5) was negative. Likewise, antibodies against neuronal surface antigens (LGI1, NMDAR, AMPAR, GABAA, mGluR1, mGluR5, DPPX, neurexin, IgLON5, CASPR2) were negative. A cell-based assay using transfected HEK293 cells confirmed the presence of anti-GABA-B R antibodies in both serum and CSF, establishing the diagnosis. He was treated with high-dose intravenous methylprednisolone (1 g daily for 5 consecutive days). Over the subsequent week, seizures resolved and sedation was tapered. During his ICU stay, he developed aspiration pneumonia with fever and leukocytosis, which was treated with a 7-day course of ceftriaxone, achieving full resolution. He was extubated after 20 days of mechanical ventilation and progressively improved, regaining orientation and basic self-care abilities. After approximately 1 month, he was transferred to the neurology ward for rehabilitation. At that time, he was alert, communicative and afebrile. His weight was 107 kg, heart rate 87 beats per minute (bpm), blood pressure 139/56 mm Hg and oxygen saturation 98% on room air. Neurological examination revealed mild short-term memory impairment but no focal deficits. Laboratory tests, including renal and hepatic function, electrolytes and inflammatory markers, were within normal limits. A 12-lead ECG showed sinus rhythm at 78 bpm, with normal PR, QRS and QT intervals, and no conduction abnormalities. Given the known paraneoplastic association of anti-GABA-B R encephalitis, a PET-CT was scheduled to evaluate for occult malignancy. However, on the night prior to the study, he was found unresponsive and pulseless during routine nursing rounds, having been last observed stable 45 min earlier. No resuscitative efforts were undertaken as he exhibited no signs of life on discovery. A clinical autopsy was performed with consent from the family. Autopsy findings Gross examination revealed perihilar lymphadenopathy. Histopathological evaluation demonstrated metastatic neuroendocrine carcinoma, compatible with a pulmonary primary, although no gross intrathoracic mass was identified at autopsy. Neuropathological examination showed chronic hypertensive vascular changes without large-vessel infarction or haemorrhage. H&E staining demonstrated perivascular lymphocytic infiltration within the brain parenchyma and meninges (figure 1A,B). Immunohistochemistry confirmed these infiltrates as CD3-positive T lymphocytes (figure 1C), consistent with inflammatory encephalitis and supporting the clinical diagnosis of anti-GABA-B R autoimmune encephalitis. (A–B) H&E staining (×40) showing perivascular lymphocytic infiltration in the central nervous system. (C) Immunohistochemistry for CD3 (×15) demonstrating perivascular CD3-positive T lymphocytes in the central nervous system. (D–E) Immunohistochemistry for CD3 (×40) showing CD3-positive T lymphocytes within myocardial fibres. (F) H&E staining (×10) showing myocardial fibres with lymphocytic infiltration. Cardiac examination revealed moderate left ventricular hypertrophy with focal interstitial fibrosis. Immunohistochemistry identified diffuse CD3-positive T lymphocytic infiltration within myocardial fibres (figure 1D,E). H&E staining confirmed perivascular and interstitial lymphocytes infiltrating the myocardium (figure 1F), consistent with lymphocytic myocarditis. No myocyte necrosis, eosinophilic infiltrates, granulomas or multinucleated giant cells were observed. Coronary arteries were patent without atherosclerotic occlusion. Other organs showed no evidence of systemic infection, drug toxicity or autoimmune disease. The autopsy concluded that the most plausible cause of sudden death was paraneoplastic lymphocytic myocarditis in the context of anti-GABA-B R encephalitis and underlying neuroendocrine carcinoma. Discussion Anti-GABA-B R encephalitis is increasingly recognised as a cause of new-onset seizures and limbic dysfunction in adults. It is strongly associated with neuroendocrine malignancies, particularly small cell lung carcinoma, supporting a paraneoplastic mechanism.2 3 The typical neuropathological features include perivascular T-cell infiltration, neuronal loss and reactive gliosis in limbic structures.4 Our case highlights two key points: first, the clinical course was typical of autoimmune encephalitis, with seizures, encephalopathy, intrathecal antibody synthesis and steroid responsiveness; second, the unexpected death revealed myocardial involvement, suggesting that anti-GABA-B R encephalitis may occasionally affect extracerebral tissues. GABA-B Rs are heterodimeric G-protein-coupled receptors (GABA-B R1 and GABA-B R2 subunits) widely expressed in the central nervous system, where they regulate neurotransmitter release, stabilise synaptic activity and contribute to learning and memory.5 Experimental evidence indicates that these receptors are also present in cardiomyocytes. Lorente et al showed that ventricular cardiomyocytes express functional GABA-B R complexes coupled to Gi/o proteins and inwardly rectifying potassium channels, modulating cardiac excitability.6 Activation with baclofen or γ-hydroxybutyrate increased potassium conductance, a mechanism with potential anti-arrhythmic effects. Beyond receptor distribution, GABAergic signalling also influences cardiovascular physiology at multiple levels. Central GABAergic activity reduces sympathetic outflow, thereby modulating heart rate and blood pressure. Peripherally, GABA receptors appear to influence electrophysiological stability and inflammatory responses within the myocardium. Chen et al reviewed evidence that GABAergic modulation reduces ischaemia-reperfusion injury, arrhythmias and oxidative stress.7 In the present case, myocarditis was characterised by CD3-positive lymphocytic infiltration without myocyte necrosis, eosinophils, granulomas or giant cells. This distinguishes it from viral myocarditis, eosinophilic myocarditis, sarcoidosis and giant cell myocarditis.8 No systemic autoimmune disease, checkpoint inhibitor therapy or infection was identified. Although direct demonstration of GABA-B R antibody binding in the myocardium was not undertaken, the combination of pathological findings, receptor expression in cardiomyocytes and absence of alternative aetiologies supports an immune-mediated mechanism. Although myocarditis was considered the most plausible cause of sudden death, alternative mechanisms must also be acknowledged. Sudden unexpected death in autoimmune encephalitis has been associated with ictal asystole, autonomic dysfunction and unwitnessed seizures, particularly in cases with limbic involvement or antibodies such as anti-GABA-B R.9 In that systematic review of 11 patients with possible or definite autoimmune encephalitis and SUDEP or ictal asystole, autoimmune encephalitis was diagnosed postmortem in only one SUDEP patient, with lymphocytic infiltration found in the amygdala and hippocampus, whereas no postmortem data were available for the remaining cases. In contrast, our patient exhibited diffuse T-cell infiltration in the myocardium, suggesting that myocarditis may have contributed to the fatal event, possibly in combination with autonomic instability. This observation has clinical implications. Sudden death in autoimmune encephalitis is often attributed to seizures, infection or cardiorespiratory complications; however, direct cardiac involvement may also play a role. Myocarditis can remain clinically silent, particularly in the absence of arrhythmias or overt heart failure, and standard ECG or echocardiography may not detect early inflammatory changes. Awareness of this possibility is essential, especially in paraneoplastic cases or when subtle cardiovascular symptoms emerge during hospitalisation. In summary, this case broadens the recognised spectrum of anti-GABA-B R encephalitis to include possible cardiac involvement. It underscores the importance of systematic cardiac monitoring in antibody-mediated encephalitis and the need for further neuropathological and immunopathogenic studies to clarify the mechanisms linking central and peripheral autoimmunity. Footnotes Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. Data availability free text: All data relevant to the study are included in the article. No additional datasets were generated or analysed. Patient consent for publication: Consent obtained from next of kin. Ethics approval: This study involves human participants. This study involved human participants but the ethics committee of the Comitè Ètic d’Investigació amb Medicaments of the Institut d’Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI/ICS) exempted this study, as it is a single anonymised case report without identifiable patient information and in accordance with institutional guidelines for the use of patient data in research publications. Written informed consent for publication of the clinical details and histopathological images was obtained from the patient’s next of kin using the BMJ deceased patient permission form. This case report complies with the principles of the Declaration of Helsinki. Participants gave informed consent to participate in the study before taking part. Provenance and peer review: Not commissioned; externally peer reviewed. Data availability statement Data sharing is not applicable as no datasets were generated and/or analysed for this study. All data relevant to the study are included in the article or uploaded as online supplemental information. References Associated Data Data Availability Statement Data sharing is not applicable as no datasets were generated and/or analysed for this study. All data relevant to the study are included in the article or uploaded as online supplemental information.